. Overview Revelation is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. We have multiple ongoing programs to evaluate Gemini, including GEM-AKI as a treatment for acute kidney injury (AKI) and GEM-CKD as a treatment for chronic kidney disease (CKD). The Company was incorporated in the state of Delaware on November 20, 2019 (originally as Petra Acquisition, Inc.) and is based in San Diego, California. ...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076552 | EDGAR | 82K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034584 | EDGAR | — |
| 2024-03-22 | 2023-12-31 | 0000950170-24-035322 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0000950170-23-011000 | EDGAR | — |
| 2022-04-15 | 2021-12-31 | 0001213900-22-020179 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001213900-21-019097 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-337967 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269450 | EDGAR | 18K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105284 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066897 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0000950170-24-124036 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0000950170-24-094727 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057787 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062025 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041851 | EDGAR | — |
| 2023-05-22 | 2023-03-31 | 0000950170-23-023313 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024436 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017405 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-338097 | EDGAR | — |
| 2026-07-13 | 0001193125-26-302008 | EDGAR | — |
| 2026-03-19 | 0001193125-26-116012 | EDGAR | 1K words |
| 2026-02-26 | 0001193125-26-076833 | EDGAR | — |
| 2026-01-29 | 0001193125-26-027742 | EDGAR | — |
| 2026-01-22 | 0001193125-26-018332 | EDGAR | — |
| 2025-12-03 | 0001193125-25-306915 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269696 | EDGAR | — |
| 2025-10-29 | 0001193125-25-256367 | EDGAR | — |
| 2025-10-15 | 0001193125-25-240400 | EDGAR | — |
160 total filings indexed. 132 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001810560 |
| Ticker | REVB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.revbiosciences.com |
| Listed | 2022-01-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/REVB (~200 tokens, structured JSON with cryptographic provenance)